C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: Results from genome-wide association and gene expression analyses followed by case-control studies

Blood

Volumn 115, Issue 23, 2010, Pages 4644-4650

  Buil, Alfonso ^a   Trégouët, David Alexandre ^b   Souto, Juan Carlos ^a   Saut, Noémie ^b   Germain, Marine ^b   Rotival, Maxime ^b   Tiret, Laurence ^b   Cambien, Françcois ^b   Lathrop, Mark ^c   Zeller, Tanja ^d   Alessi, Marie Christine ^b   De Cordoba, Santiago Rodriguez ^e   Münzel, Thomas ^d   Wild, Philipp ^d   Fontcuberta, Jordi ^a   Gagnon, France ^f   Emmerich, Joseph ^b   Almasy, Laura ^g   Blankenberg, Stefan ^d   Soria, José Manuel ^a   Morange, Pierre Emmanuel ^b   more..

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSERM   (France)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^f UNIVERSITY OF TORONTO   (Canada)

^g SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN ALPHA6BETA1; COMPLEMENT COMPONENT C4B BINDING PROTEIN ALPHA7BETA; COMPLEMENT COMPONENT C4B BINDING PROTEIN ALPHA7BETA1; MESSENGER RNA; PROTEIN S; UNCLASSIFIED DRUG; C4BPA PROTEIN, HUMAN; C4BPB PROTEIN, HUMAN; HISTOCOMPATIBILITY ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS; BLOOD; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; RISK FACTOR;

CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN S; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77954752114     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-263038     Document Type: Article

References (45)

1. de Wolf CJ, Cupers RM, Bertina RM, Vos HL. Interleukin-6 induction of protein s is regulated through signal transducer and activator of transcription 3. Arterioscler Thromb Vasc Biol. 2006;26(9):2168-2174.
2. Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol. 2008;15(5):529-536.
3. Koedam JA, Meijers JC, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest. 1988;82(4):1236-1243.
4. Shen L, Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994;269(29):18735-18738. (Pubitemid 24226180)
5. Seré KM, Rosing J, Hackeng TM. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood. 2004;104(12):3624-3630. (Pubitemid 39564437)
6. Hackeng TM, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A. 2006;103(9):3106-3111. (Pubitemid 43346432)
7. Griffin JH, Gruber A, Fernandez JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood. 1992;79(12):3203-3211.
8. Dahlbäck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A. 1981;78(4):2512-2516. (Pubitemid 11048838)
9. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986;261(26):12022-12027. (Pubitemid 17202758)
10. Dahlbäck B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost. 2007;98(1):90-96. (Pubitemid 47074183)
11. Maurissen LF, Thomassen MC, Nicolaes GA, et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 2008;111(6):3034-3041.
12. van de Poel RH, Meijers JC, Rosing J, Tans G, Bouma BN. C4b-binding protein protects coagulation factor Va from inactivation by activated protein C. Biochemistry. 2000;39(47):14543-14548.
13. García de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost. 2007;98(3):543-556.
14. Engesser L, BroekmansAW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987;106(5):677-682. (Pubitemid 17067983)
15. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984;311(24):1525-1528.
16. Esparza-Gordillo J, Soria JM, Buil A, et al. Genetic correlation between plasma levels of C4BP isoforms containing beta chains and susceptibility to thrombosis. J Med Genet. 2004;41(1):e5.
17. Lijfering WM, Mulder R, ten Kate MK, Veeger NJ, Mulder AB, van der Meer J. Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives. Blood. 2009;113(6):1225-1230.
18. Scharfstein J, Ferreira A, Gigli I, Nussenzweig V. Human C4-binding protein: I, isolation and characterization. J Exp Med. 1978;148(1):207-222. (Pubitemid 8376489)
19. Blom AM, Villoutreix BO, Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol Immunol. 2004;40(18):1333-1346. (Pubitemid 38456985)
20. Esparza-Gordillo J, Soria JM, Buil A, et al. Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families. Immunogenetics. 2003;54(12):862-866. (Pubitemid 36470080)
21. Sánchez-Corral P, Criado Garcia O, Rodriguez de Cordoba S. Isoforms of human C4b-binding protein: I, molecular basis for the C4BP isoform pattern and its variations in human plasma. J Immunol. 1995;155(8):4030-4036.
22. Souto JC, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study: genetic analysis of idiopathic thrombophilia. Am J Hum Genet. 2000;67(6):1452-1459.
23. Zeller T, Wild P, Szymczak S, et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE. 2010;5(5):e10693.
24. Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009;113(21):5298-5303.
25. Hercberg S, Galan P, Preziosi P, et al. The SU.VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164(21):2335-2342. (Pubitemid 39532244)
26. Mälarstig A, Buil A, Souto JC, et al. Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genomewide association study. Blood. 2009;114(7):1417-1422.
27. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62(5):1198-1211. (Pubitemid 28199022)
28. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics. 2007;23(8):1038-1039. (Pubitemid 47050595)
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
30. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53(4):1253-1261.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748.
32. Huber W, von Heydebreck A, Sültmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(suppl 1):S96-S104
33. International HapMap Project. HapMap. http://hapmap.ncbi.nlm.nih.gov. Accessed November 12, 2009.
34. Almasy L, Soria JM, Souto JC, et al. A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project. Arterioscler Thromb Vasc Biol. 2003;23(3):508-511.
35. Criado García O, Sanchez-Corral P, Rodriguez de Cordoba S. Isoforms of human C4b-binding protein: II, differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J Immunol. 1995;155(8):4037-4043.
36. García de Frutos P, Alim RI, Hardig Y, Zoller B, Dahlback B. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood. 1994;84(3):815-822.
37. Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1(7):1343-1348.
38. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009;54(8):669-677.
39. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8):1544-1551.
40. Reiner AP, Lange LA, Smith NL, Zakai NA, Cushman M, Folsom AR. Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost. 2009;7(9):1499-1505.
41. Blom AM, Villoutreix BO, Dahlback B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch Immunol Ther Exp (Warsz). 2004;52(2):83-95. (Pubitemid 38685048)
42. Happonen KE, Sjoberg AP, Morgelin M, Heinegard D, Blom AM. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix. J Immunol. 2009;182(3):1518-1525.
43. Saeki T, Hirose S, Nukatsuka M, Kusunoki Y, Nagasawa S. Evidence that C4b-binding protein is an acute phase protein. Biochem Biophys Res Commun. 1989;164(3):1446-1451. (Pubitemid 19284007)
44. Trouw LA, Okroj M, Kupreishvili K, et al. C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3. PLoS ONE. 2008;3(8):e2886. doi:10.1371/journal.pone.0002886.
45. Morange PE, Tregouet DA. Deciphering the molecular basis to venous thromboembolism: where are we and where should we go? Br J Haematol. 2010;148(4):495-506.